Literature DB >> 5080719

An inhibitor in human lung macrophages active against human neutrophil elastase.

J Blondin, R Rosenberg, A Janoff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5080719     DOI: 10.1164/arrd.1972.106.3.477

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


× No keyword cloud information.
  8 in total

1.  Sequence and molecular characterization of human monocyte/neutrophil elastase inhibitor.

Authors:  E Remold-O'Donnell; J Chin; M Alberts
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

2.  Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage.

Authors:  G W Hunninghake; J E Gadek; O Kawanami; V J Ferrans; R G Crystal
Journal:  Am J Pathol       Date:  1979-10       Impact factor: 4.307

3.  Irreversible bronchial goblet cell metaplasia in hamsters with elastase-induced panacinar emphysema.

Authors:  T G Christensen; A L Korthy; G L Snider; J A Hayes
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

4.  Alpha-1-antitrypsin content in the serum, alveolar macrophages, and alveolar lavage fluid of smoking and nonsmoking normal subjects.

Authors:  G N Olsen; J O Harris; J R Castle; R H Waldman; H J Karmgard
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

5.  Interrelationships between the human alveolar macrophage and alpha-1-antitrypsin.

Authors:  A B Cohen
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

Review 6.  The alveolar macrophage.

Authors:  D H Bowden
Journal:  Environ Health Perspect       Date:  1984-04       Impact factor: 9.031

7.  A fast-acting elastase inhibitor in human monocytes.

Authors:  E Remold-O'Donnell
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

8.  Elastase inhibitor. Characterization of the human elastase inhibitor molecule associated with monocytes, macrophages, and neutrophils.

Authors:  E Remold-O'Donnell; J C Nixon; R M Rose
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.